Metformin is often associated with lactic acidosis, especially in patients with kidney disease. A recently published study questions this association in patients with mild to moderate disease.

A small pilot study investigates how modest hyperglycemia, not hyperinsulinemia, is better for people with type 1 diabetes during exercise.

Canaglifozin reduced risk of cardiovascular death and hospitalizations due to heart failure by 31%.

Are you doing everything you can to ensure your patient has the best quality of life possible with type 2 diabetes?

SGLT-2 inhibitors show additional benefits besides lowering blood glucose.

Can an increase in waist circumference determine cardiovascular risk, separate from weight loss or gain?

Study of the Danish national register suggests that family members’ age at onset of diabetes could be an essential factor that is overlooked in determining type 2 risk.

Continuous glucose monitoring systems can enable pregnant women to monitor blood glucose more effectively. 

Can exposure to particulate matter in air pollution increase an individual’s risk for type 2 diabetes? 

Examining the effects of GLP-1RAs exenatide and liraglutide on weight and insulin dosage for type 1 diabetes patients.